BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 1078552)

  • 21. Immune function in patients with multiple myeloma (delayed cutaneous reactivity and lymphocytes bearing receptors for sheep, human and mouse erythrocytes).
    Dammacco F; Miglietta A; Bonomo L
    Ric Clin Lab; 1977; 7(4):343-53. PubMed ID: 307801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of thymosin on human T-cells from cancer patients.
    Hardy MA; Dattner AM; Sarkar DK; Stoffer JA; Friedmann N
    Cancer; 1976 Jan; 37(1):98-103. PubMed ID: 1082366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human thymus lymphoid tissue (HTL) antigen, complement receptor and rosette formation with sheep erythrocytes of the lymphocytes from primary immunodeficiency diseases.
    Yata J; Tsukimoto I; Arimoto T; Goya N; Tachibana T
    Clin Exp Immunol; 1973 Jul; 14(3):309-17. PubMed ID: 4579777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of T lymphocyte differentiation in vitro by thymic extracts and purified polypeptides in severe combined immunodeficiency diseases.
    Incefy GS; Boumsell L; Kagan W; Goldstein G; Sousa MD; Smithwick E; O'Reilly R; Good RA
    Trans Assoc Am Physicians; 1975; 88():135-45. PubMed ID: 772925
    [No Abstract]   [Full Text] [Related]  

  • 25. Thymosin treatment of children with primary immunodeficiency disease.
    Wara DW; Ammann AJ
    Transplant Proc; 1978 Mar; 10(1):203-9. PubMed ID: 305674
    [No Abstract]   [Full Text] [Related]  

  • 26. Cellular immunodeficiency with immunoglobulins: treatment with a thymus implant in millipore diffusion chambers.
    García Rodríguez MC; Fontán G; Alba J; Lorente F; Segurado E; García de Miguel MJ; Ojeda JA
    Allergol Immunopathol (Madr); 1979; 7(5):337-44. PubMed ID: 317215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymic hormone dependent immunodeficiency in an infant with partial trisomy of chromosome 22.
    Tovo PA; Davi G; Fraceschini P; Delpiano A
    Thymus; 1986; 8(5):313-8. PubMed ID: 3798528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TFX immunotherapy in children with ALL during remission.
    Traczewska M; Chmielewska D; Ochocka M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):525-36. PubMed ID: 2414181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and experimental justification for using thymus preparations for the treatment of infectious and allergic diseases of the respiratory organs caused by changes in the thymus-dependent immunity system].
    Giulling EV
    Zh Ushn Nos Gorl Bolezn; 1977; (6):53-7. PubMed ID: 304287
    [No Abstract]   [Full Text] [Related]  

  • 30. T- and B-lymphocytes in immunological disorders.
    Yata J; Okumura K; Nakagawa T; Sumiya M
    Allerg Immunol (Leipz); 1974-1975; 20-21(4):403-12. PubMed ID: 4377862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial: Thymus hormones.
    Lancet; 1975 Feb; 1(7902):314-5. PubMed ID: 46451
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunodeficiency diseases. I. T-lymphocyte precursors and T-lymphocyte differentiation in partial Di George syndrome.
    Touraine JL; Touraine F; Dutruge J; Gilly J; Colon S; Gilly R
    Clin Exp Immunol; 1975 Jul; 21(1):39-46. PubMed ID: 1081021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lymphoid system: abnormalities in immunodeficiency and malignancy.
    Kersey JH; Gajl-Peczalska KJ; Nesbit ME
    J Pediatr; 1974 Jun; 84(6):789-96. PubMed ID: 4596997
    [No Abstract]   [Full Text] [Related]  

  • 34. Thymus transplants: a look to the future.
    Hong R
    Birth Defects Orig Artic Ser; 1975; 11(1):357-60. PubMed ID: 1080059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: Transfer factor, thymosin and E rosettes.
    Khan A; Sellars WA; Goble P; Thometz D
    N Engl J Med; 1975 Apr; 292(16):868-9. PubMed ID: 1167286
    [No Abstract]   [Full Text] [Related]  

  • 36. B lymphocytes, T lymphocytes and phytohaemagglutinin responsiveness in atopic dermatitis.
    Andersen E; Hjorth N
    Acta Derm Venereol; 1975; 55(5):345-9. PubMed ID: 52969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymosin in cancer patients: in vitro effects and correlations with clinical response to thymosin immunotherapy.
    Chretien PB; Lipson SD; Makuch R; Kenady DE; Cohen MH; Minna JD
    Cancer Treat Rep; 1978 Nov; 62(11):1787-90. PubMed ID: 215307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe variable immunodeficiency disorder with absence of thymus and IgA.
    Yamshon D; Hyde JS
    Ann Allergy; 1975 Apr; 34(4):219-25. PubMed ID: 1092211
    [No Abstract]   [Full Text] [Related]  

  • 39. Restorative effect of normal human serum, transfer factor and thymosin on the ability of heated human lymphocytes to form rosettes with sheep erythrocytes.
    Mendes NF; Saraiva PJ; Santos OB
    Cell Immunol; 1975 Jun; 17(2):560-6. PubMed ID: 165007
    [No Abstract]   [Full Text] [Related]  

  • 40. Correction of T cell function by thymosin in New Zealand mice.
    Gershwin ME; Ahmed A; Steinberg AD; Thurman GB; Goldstein AL
    J Immunol; 1974 Sep; 113(3):1068-71. PubMed ID: 4606393
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.